Dr. Paul W. Hannam, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 425 E Cherry St, Troy, MO 63379 Phone: 636-622-9050 Fax: 636-622-9060 |
News Archive
A recent study by Professor Monique Raats of the University of Surrey's Food, Consumer Behaviour and Health Research Centre, in conjunction with the European Food Information Council in Brussels, has shown that consumers do take into account reference amounts displayed on front of pack nutrition labelling when making their judgements of healthfulness, thus highlighting their importance for the effective presentation of nutrition information.
Soligenix, Inc., a late-stage biotechnology company, announced today the publication of an article in the February 2010 edition of Vaccine, which describes preclinical formulations of RiVax™, its ricin toxin vaccine, with heightened stability. The article was authored by the Company's collaborators at the University of Texas Southwestern Medical Center at Dallas (UT Southwestern) where the vaccine originated. RiVax™ is currently being evaluated in Phase 1 human safety and immunogenicity trials, as well as non-human primate trials for efficacy.
Editors at the prestigious New England Journal of Medicine urge the nation's physicians to make their views on the health law known to their congressional representatives, noting their own favorable stance, while a conservative Georgia district urges the House GOP to keep up its fight to defund the law.
Medicaid beneficiaries with lupus are not adequately following their treatment plans, and this puts them at risk for poor health outcomes, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego. For most lupus medications, fewer than one in three beneficiaries were found to be adherent.
› Verified 5 days ago